We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biodefense Bill May Jeopardize Orphan Drug Development
Biodefense Bill May Jeopardize Orphan Drug Development
June 2, 2006
A provision in pending legislation granting extended market exclusivity for drugs used to address potential bioterrorism threats could undercut current law, is unnecessary and must be removed, patient advocates say.